Navigation Links
Genesis Biosystems Unveils Innovative Skin Treatment at Esthétique SPA International Trade Show
Date:2/12/2013

Dallas, TX (PRWEB) February 12, 2013

Genesis Biosystems Inc., a leading manufacturer of professional microdermabrasion equipment will be a fresh face at the 2013 Esthétique SPA International trade show in Las Vegas, February 24-25, 2013. The show, held at the Venetian Sands Expo, focuses on the aesthetic, spa and wellness industries, and brings together spa owners, esthetic professionals, and esthetic equipment manufacturers for networking, sharing of best practices, and training on new techniques and technologies. “This is our first year to exhibit at this show,” says Chris Jackson, VP of Sales and Marketing. “It gives us a great opportunity to network with spa owners, and to share information about customer satisfaction. We are very excited to participate.”

Genesis Biosystems is also excited to introduce the DermaFrac™ Micro-Channeling System, an innovative dermal micro-channeling treatment. A lower-cost alternative to fractional laser treatments, the system creates micro-channels to the dermal-epidermal junction and simultaneously infuses high grade topicals directly into this tissue layer. Precisely calibrated micro-needles, which can be administered by an aesthetician, offer a deeper active infusion of topicals and provide for a completely painless procedure without the need for anesthesia.

Genesis Biosystems will demo the DermaFrac system in booths 213-215 at this year’s Esthétique SPA trade show. They will also host a clinical hands-on demonstration class, Microneedling and DermaFrac™- Compare and Contrast, Sunday, February 24, at 1:30 pm in room 305, which will introduce DermaFrac technology and teach participating estheticians
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. ThermoGenesis Announces Approval of AXP® by India Ministry of Health
2. Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
3. ValGenesis Suite 2.5 Certified by SAP as Powered by SAP NetWeaver®
4. Genesis Biopharma Announces Proposed Public Offering of Common Stock and Warrants
5. Genesis Biopharma Issues Letter To Shareholders
6. Genesis Biopharma Mentioned Favorably in BioMedReports Article
7. Organogenesis Announces Annual College Scholarship Award Winner
8. Ahram Biosystems Announces Launch of the New Economy Model F1-12 of Its Palm PCR Series
9. Aushon BioSystems Appoints Martin Verhoef Chief Executive Officer
10. AyoxxA Biosystems Closes Series A Financing Round
11. Aushon BioSystems and AH diagnostics Sign Distribution Deal for Scandinavia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015 Pipette.com has added the ... their comprehensive portfolio of Eppendorf products. , The Eppendorf ... a Centrifuge 5424/5424 R and receive the following:, ... Research plus or Eppendorf Reference 2 , ...
(Date:1/22/2015)... Selexis SA, a serial innovation company ... (RCBs) used for drug discovery to commercial manufacturing, announced ... Next-Generation Sequencing (NGS) data packages. The NGS ... by ensuring the integrity of the gene, validation of ...
(Date:1/22/2015)... , Jan. 22. 2015  Varian Medical Systems (NYSE: ... been honored for its commitment to sustainability with inclusion on ... is the highest ranked healthcare equipment company among the Corporate ... the World Economic Forum at Davos, Switzerland ...
(Date:12/24/2014)... 24, 2014  United Therapeutics Corporation (NASDAQ: UTHR ... MDT ) has submitted a pre-market approval application to ... use of Medtronic,s SynchroMed ® II implantable drug ... with United Therapeutics, Remodulin ® (treprostinil) Injection delivered ...
Breaking Biology Technology:Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2Varian Honored Among World's 100 Most Sustainable Corporations 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
... Genoptix, Inc.,(Nasdaq: GXDX ), a specialized laboratory ... BIOCOM Investor Conference 2008,scheduled to take place at ... October,26-28, 2008., Dr. Tina Nova, President and ... Monday, October 27, beginning at approximately 9:30 a.m. ...
... Days Faster Test Results Enable Physicians to Direct Earlier, Effective, ... ... Infections and Save Lives(1), WOBURN, Mass., Oct. 22 ... AdvanDx,s PNA FISH(TM) test reduced,mortality by 42% for patients with ...
... or the "Company") (Nasdaq and MTA: CTIC) today ... $24.7 million, newly,issued 9.66% Convertible Senior Notes due ... The new Notes would have a $24.7 ... entitling the holder, upon any conversion of,the Notes, ...
Cached Biology Technology:Genoptix Announces Participation at the BIOCOM Investor Conference 2008 2AdvanDx's PNA FISH(TM) Test Shown to Reduce Mortality by 42% for Patients With Hospital-Acquired Enterococcus faecium Bloodstream Infections 2AdvanDx's PNA FISH(TM) Test Shown to Reduce Mortality by 42% for Patients With Hospital-Acquired Enterococcus faecium Bloodstream Infections 3AdvanDx's PNA FISH(TM) Test Shown to Reduce Mortality by 42% for Patients With Hospital-Acquired Enterococcus faecium Bloodstream Infections 4AdvanDx's PNA FISH(TM) Test Shown to Reduce Mortality by 42% for Patients With Hospital-Acquired Enterococcus faecium Bloodstream Infections 5Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $24.7 Million of Senior Convertible Notes 2Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $24.7 Million of Senior Convertible Notes 3
(Date:12/17/2014)... , Dec. 16, 2014 Research and Markets ... the "Global Chemical Sensor Market 2015-2019" report ... One major trend upcoming in this ... biomedical applications. Chemical sensors help in recording of patient ...
(Date:12/11/2014)... 2014 Research and Markets , ... has announced the addition of the "Biometrics Market ... One major trend emerging in this market ... systems utilize more than one characteristic of an individual ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Valencell, a leader ... is seeing a staggering demand from its licensees for ... Company revealed, is not solely coming from fitness and ... well. "A wearable is only as useful ...
Breaking Biology News(10 mins):Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... How do viruses get into cells? In pursuing this central ... 1997, and his team have pioneered research in this field. ... Swiss Nobel Prize in Bern, Switzerland. This award is not ... a confirmation of our long years of work, and demonstration ...
... academic entrepreneurs has teamed up with the University ... in membrane biology to pharmaceutical, biotech and agrochemical ... spin-out company Oxford Molecular into a business worth ... for Integrative Membrane Biology (CIMB) to broker research ...
... 24 years ago in Montana has,finally been identified ... Asian dinosaurs. The dinosaur would have weighed 30 to ... feet tall. The fossil,came from sediment that,s about 80 ... was published in September,s issue of the Journal,of Vertebrate ...
Cached Biology News:ETH Zurich professor Ari Helenius awarded Benoist Prize 2New partnership offers outsourced R&D in membrane biology 2New dinosaur species found in Montana 2
...
... Immunogen: Synthetic peptide derived from ... rat mouse dog and orangutang occludin ... human occludin protein. Reactivity: Human ... Reactivity with rat mouse dog and ...
...
TRIzol Reagents are ready-to-use monophasic solutions of phenol and guanidine isothiocyanate suitable for isolating total RNA DNA and proteins (16)....
Biology Products: